✦ LIBER ✦

Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation

✍ Scribed by Snijders, Rosalinde J.M.; Sebire, Neil J.; Nayar, Roshini; Souka, Athena; Nicolaides, Kypros H.

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 14 KB
Volume: 86
Category: Article
ISSN: 0148-7299
DOI: 10.1002/(sici)1096-8628(19990917)86:3<205::aid-ajmg2>3.0.co;2-n

No coin nor oath required. For personal study only.

✦ Synopsis

In a multicenter screening study for trisomy 21 involving ultrasonographic measurement of fetal nuchal translucency thickness (NT) at 10-14 weeks of gestation, 100,311 singleton pregnancies with a live fetus were examined. There were 46 cases of trisomy 13, and in 33 (72%) of these, the NT was above the 95th centile. The estimated risk for trisomy 21, based on maternal age-related risk for this chromosomal abnormality and fetal NT, was above 1 in 300 in 37 (80.1%) of the trisomy 13 fetuses. The fetal crown-rump length was significantly reduced, but the fetal heart rate was increased, being above the 95th centile in 64% of cases. Additionally, 24% of trisomy 13 fetuses had holoprosencephaly and 10% had exomphalos. This study has demonstrated that at 10-14 weeks of gestation, about 80% of fetuses with trisomy 13 can be identified in a screening program for trisomy 21, based on a combination of maternal age and fetal NT.

📜 SIMILAR VOLUMES

The distribution of nuchal translucency

The distribution of nuchal translucency at 10–13 weeks of pregnancy

✍ Katharina Schuchter; Nicholas Wald; Allan K. Hackshaw; Erich Hafner; Eva Liebhar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

There is a need for a simple method of expressing nuchal translucency measurement in early pregnancy that will allow for gestational age and be useful in screening for Down's syndrome. To achieve this objective, we conducted a prospective study of 561 women with singleton pregnancies that were not a

Screening for trisomy 13 by fetal nuchal

Screening for trisomy 13 by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Kevin Spencer; Charas Ong; Hara Skentou; Adolfo W. Liao; Kypros H. Nicolaides 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

In 42 cases of trisomy 13 at 10±14 weeks of gestation, compared with 947 controls, the median multiple of the median (MoM) of maternal serum free b-human chorionic gonadotrophin (b-hCG) and pregnancy associated plasma protein A (PAPP-A) was signi®cantly decreased (0.506 MoM and 0.248 MoM respectivel

UMBILICAL DOPPLER VELOCIMETRY IN FETUSES

UMBILICAL DOPPLER VELOCIMETRY IN FETUSES WITH TRISOMY 18 AT 10–18 WEEKS' GESTATION

✍ J. M. MARTINEZ; E. ANTOLIN; A. BORRELL; B. PUERTO; E. CASALS; J. OJUEL; A. FORTU 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

The aim of our study was to obtain measurements of the umbilical artery pulsatility index (PI) in pregnancies before invasive procedures for prenatal diagnosis, in order to investigate its potential prognostic value in predicting trisomy 18. We performed a prospective study including 1785 consecutiv

Detection of sex chromosome abnormalitie

Detection of sex chromosome abnormalities by nuchal translucency screening at 10–14 weeks

✍ N. J. Sebire; R. J. M. Snijders; R. Brown; T. Southall; K. H. Nicolaides 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

At 10-14 weeks of gestation more than 80 per cent of fetuses affected by trisomy 21 can be detected by a screening programme based on a combination of maternal age and fetal nuchal translucency thickness (NT). The screen positive group in such a programme also identifies fetuses with sex chromosome

Screening for trisomy 18 by fetal nuchal

Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10–14 weeks of gestation

✍ Natasha Tul; Kevin Spencer; Penelope Noble; Christine Chan; Kypros Nicolaides 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

In a study of 50 cases of trisomy 18 compared with 947 controls we have found the median multiple of the median (MoM) of maternal serum free human chorionic gonadotrophin to be significantly decreased (0.281 MoM) in samples collected between the 10th and 14th week of gestation. Similarly, maternal s

Results of routine fetal nuchal transluc

Results of routine fetal nuchal translucency measurement at weeks 10–13 in 4233 unselected pregnant women

✍ E. Hafner; K. Schuchter; E. Liebhart; K. Philipp 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

The aim of this study was to determine the value of nuchal translucency (NT) measurement for the detection of aneuploidies and other malformations in a low-risk population. In total, 4233 women who booked in our hospital for delivery were examined between the tenth and 13th week of gestation. Of the